Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 79

1.

Octreotide therapy of pediatric hypothalamic obesity: a double-blind, placebo-controlled trial.

Lustig RH, Hinds PS, Ringwald-Smith K, Christensen RK, Kaste SC, Schreiber RE, Rai SN, Lensing SY, Wu S, Xiong X.

J Clin Endocrinol Metab. 2003 Jun;88(6):2586-92.

PMID:
12788859
[PubMed - indexed for MEDLINE]
2.

A multicenter, randomized, double-blind, placebo-controlled, dose-finding trial of a long-acting formulation of octreotide in promoting weight loss in obese adults with insulin hypersecretion.

Lustig RH, Greenway F, Velasquez-Mieyer P, Heimburger D, Schumacher D, Smith D, Smith W, Soler N, Warsi G, Berg W, Maloney J, Benedetto J, Zhu W, Hohneker J.

Int J Obes (Lond). 2006 Feb;30(2):331-41.

PMID:
16158082
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Hypothalamic obesity caused by cranial insult in children: altered glucose and insulin dynamics and reversal by a somatostatin agonist.

Lustig RH, Rose SR, Burghen GA, Velasquez-Mieyer P, Broome DC, Smith K, Li H, Hudson MM, Heideman RL, Kun LE.

J Pediatr. 1999 Aug;135(2 Pt 1):162-8.

PMID:
10431109
[PubMed - indexed for MEDLINE]
4.

Circulating ghrelin levels are suppressed by meals and octreotide therapy in children with Prader-Willi syndrome.

Haqq AM, Stadler DD, Rosenfeld RG, Pratt KL, Weigle DS, Frayo RS, LaFranchi SH, Cummings DE, Purnell JQ.

J Clin Endocrinol Metab. 2003 Aug;88(8):3573-6.

PMID:
12915638
[PubMed - indexed for MEDLINE]
5.

Insulin dynamics predict body mass index and z-score response to insulin suppression or sensitization pharmacotherapy in obese children.

Lustig RH, Mietus-Snyder ML, Bacchetti P, Lazar AA, Velasquez-Mieyer PA, Christensen ML.

J Pediatr. 2006 Jan;148(1):23-9.

PMID:
16423593
[PubMed - indexed for MEDLINE]
Free PMC Article
6.
7.

A randomized, double-blind, placebo-controlled trial of metformin treatment of weight gain associated with initiation of atypical antipsychotic therapy in children and adolescents.

Klein DJ, Cottingham EM, Sorter M, Barton BA, Morrison JA.

Am J Psychiatry. 2006 Dec;163(12):2072-9.

PMID:
17151157
[PubMed - indexed for MEDLINE]
8.

Suppression of insulin secretion is associated with weight loss and altered macronutrient intake and preference in a subset of obese adults.

Velasquez-Mieyer PA, Cowan PA, Arheart KL, Buffington CK, Spencer KA, Connelly BE, Cowan GW, Lustig RH.

Int J Obes Relat Metab Disord. 2003 Feb;27(2):219-26.

PMID:
12587002
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Sibutramine is effective for weight loss and diabetic control in obesity with type 2 diabetes: a randomised, double-blind, placebo-controlled study.

Finer N, Bloom SR, Frost GS, Banks LM, Griffiths J.

Diabetes Obes Metab. 2000 Apr;2(2):105-12.

PMID:
11220522
[PubMed - indexed for MEDLINE]
10.

Bromocriptine: a novel approach to the treatment of type 2 diabetes.

Pijl H, Ohashi S, Matsuda M, Miyazaki Y, Mahankali A, Kumar V, Pipek R, Iozzo P, Lancaster JL, Cincotta AH, DeFronzo RA.

Diabetes Care. 2000 Aug;23(8):1154-61.

PMID:
10937514
[PubMed - indexed for MEDLINE]
Free Article
11.

[Decrease in serum ghrelin levels in patients with acromegaly normalize after successful surgical treatment].

Kozakowski J, Rabijewski M, Zgliczyński W.

Endokrynol Pol. 2005 Nov-Dec;56(6):862-70. Polish.

PMID:
16821203
[PubMed - indexed for MEDLINE]
12.

The effect of salsalate on insulin action and glucose tolerance in obese non-diabetic patients: results of a randomised double-blind placebo-controlled study.

Koska J, Ortega E, Bunt JC, Gasser A, Impson J, Hanson RL, Forbes J, de Courten B, Krakoff J.

Diabetologia. 2009 Mar;52(3):385-93. doi: 10.1007/s00125-008-1239-x. Epub 2008 Dec 23.

PMID:
19104769
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Impact sibutramine therapy in children with hypothalamic obesity or obesity with aggravating syndromes.

Danielsson P, Janson A, Norgren S, Marcus C.

J Clin Endocrinol Metab. 2007 Nov;92(11):4101-6. Epub 2007 Aug 28.

PMID:
17726084
[PubMed - indexed for MEDLINE]
14.

Variation of inflammatory parameters after sibutramine treatment compared to placebo in type 2 diabetic patients.

Derosa G, Maffioli P, Ferrari I, Palumbo I, Randazzo S, D'Angelo A, Cicero AF.

J Clin Pharm Ther. 2011 Oct;36(5):592-601. doi: 10.1111/j.1365-2710.2010.01217.x. Epub 2010 Nov 12.

PMID:
21070297
[PubMed - indexed for MEDLINE]
15.

Continuation of growth hormone (GH) replacement in GH-deficient patients during transition from childhood to adulthood: a two-year placebo-controlled study.

Vahl N, Juul A, Jørgensen JO, Orskov H, Skakkebaek NE, Christiansen JS.

J Clin Endocrinol Metab. 2000 May;85(5):1874-81.

PMID:
10843168
[PubMed - indexed for MEDLINE]
16.

Randomized, controlled trial of metformin for obesity and insulin resistance in children and adolescents: improvement in body composition and fasting insulin.

Srinivasan S, Ambler GR, Baur LA, Garnett SP, Tepsa M, Yap F, Ward GM, Cowell CT.

J Clin Endocrinol Metab. 2006 Jun;91(6):2074-80. Epub 2006 Apr 4.

PMID:
16595599
[PubMed - indexed for MEDLINE]
17.

Effects of a combination of recombinant human growth hormone with metformin on glucose metabolism and body composition in patients with metabolic syndrome.

Herrmann BL, Berg C, Vogel E, Nowak T, Renzing-Koehler K, Mann K, Saller B.

Horm Metab Res. 2004 Jan;36(1):54-61.

PMID:
14983408
[PubMed - indexed for MEDLINE]
18.

Body composition in active acromegaly during treatment with octreotide: a double-blind, placebo-controlled cross-over study.

Hansen TB, Gram J, Bjerre P, Hagen C, Bollerslev J.

Clin Endocrinol (Oxf). 1994 Sep;41(3):323-9.

PMID:
7955439
[PubMed - indexed for MEDLINE]
19.

Childhood craniopharyngioma: greater hypothalamic involvement before surgery is associated with higher homeostasis model insulin resistance index.

Trivin C, Busiah K, Mahlaoui N, Recasens C, Souberbielle JC, Zerah M, Sainte-Rose C, Brauner R.

BMC Pediatr. 2009 Apr 2;9:24. doi: 10.1186/1471-2431-9-24.

PMID:
19341477
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Weight reduction effects of a black soy peptide supplement in overweight and obese subjects: double blind, randomized, controlled study.

Kwak JH, Ahn CW, Park SH, Jung SU, Min BJ, Kim OY, Lee JH.

Food Funct. 2012 Oct;3(10):1019-24. Epub 2012 Jun 28.

PMID:
22739624
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk